Author

S.-b. Wang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. Varshney· 1 shared B. Gelfand· 1 shared B. Werner· 1 shared C. Stains· 1 shared E. Taylor· 1 shared F. Pereira· 1 shared H. Leung· 1 shared I. Apicella· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Varshney

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of Fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration

M. Ambati, I. Apicella, S. Narendran, S.-b. Wang, H. Leung, F. Pereira, A. Varshney, M. Shadmehr, C. Stains, B. Werner, K. Baker, K. Marion, S. Sadda, E. Taylor, J. Magagnoli, , B. Gelfand

This paper identifies fluoxetine as a potential repurposed drug for dry AMD by showing it inhibits NLRP3-ASC inflammasome activation and reduces RPE degeneration in mice, supported by epidemiological data.

bioRxiv · Jan 11, 2021Immunology